Sutro Biopharma, Inc. (STRO) Reports Q2 Loss, Beats Revenue Estimates

Sutro Biopharma, Inc. (STRO) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of $0.39. This compares to a loss of $0.59 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +64.10%. A quarter ago, it was expected that this company would post a loss of $0.63 per share when it actually produced a loss of $0.91, delivering a surprise of -44.44%.Over the last four quarters, the company ha ...